CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,955 | -50.9% | 10,883 | -66.1% | 0.00% | – |
| Q2 2023 | $749,155 | -80.4% | 32,125 | -82.3% | 0.00% | -100.0% |
| Q4 2022 | $3,817,388 | -34.7% | 181,867 | -13.8% | 0.00% | -33.3% |
| Q3 2022 | $5,845,000 | +11.1% | 211,026 | +1.7% | 0.00% | +50.0% |
| Q2 2022 | $5,260,000 | +718.0% | 207,423 | +682.6% | 0.00% | – |
| Q1 2022 | $643,000 | +18.2% | 26,505 | -5.0% | 0.00% | – |
| Q4 2021 | $544,000 | -25.6% | 27,903 | -22.5% | 0.00% | – |
| Q3 2021 | $731,000 | -13.6% | 36,021 | -5.1% | 0.00% | – |
| Q2 2021 | $846,000 | +19.7% | 37,946 | +23.1% | 0.00% | – |
| Q1 2021 | $707,000 | -46.3% | 30,836 | -36.7% | 0.00% | -100.0% |
| Q4 2020 | $1,316,000 | +727.7% | 48,737 | +441.6% | 0.00% | – |
| Q3 2020 | $159,000 | -22.1% | 8,998 | -26.2% | 0.00% | – |
| Q2 2020 | $204,000 | +325.0% | 12,195 | +203.7% | 0.00% | – |
| Q1 2020 | $48,000 | -76.2% | 4,016 | -75.8% | 0.00% | – |
| Q4 2019 | $202,000 | -2.4% | 16,628 | +13.4% | 0.00% | – |
| Q3 2019 | $207,000 | +31.0% | 14,659 | +3.2% | 0.00% | – |
| Q2 2019 | $158,000 | +285.4% | 14,201 | +302.6% | 0.00% | – |
| Q1 2019 | $41,000 | -35.9% | 3,527 | -27.0% | 0.00% | – |
| Q4 2018 | $64,000 | +25.5% | 4,831 | +33.1% | 0.00% | – |
| Q3 2018 | $51,000 | -74.6% | 3,629 | -71.7% | 0.00% | – |
| Q2 2018 | $201,000 | -23.6% | 12,802 | -19.8% | 0.00% | – |
| Q1 2018 | $263,000 | -81.4% | 15,965 | -79.6% | 0.00% | -100.0% |
| Q4 2017 | $1,415,000 | +170.0% | 78,310 | +188.3% | 0.00% | – |
| Q3 2017 | $524,000 | +26.9% | 27,161 | -22.2% | 0.00% | – |
| Q2 2017 | $413,000 | +126.9% | 34,931 | +111.2% | 0.00% | – |
| Q1 2017 | $182,000 | +31.9% | 16,542 | 0.0% | 0.00% | – |
| Q4 2016 | $138,000 | +60.5% | 16,542 | +24.8% | 0.00% | – |
| Q3 2016 | $86,000 | -14.0% | 13,254 | -28.1% | 0.00% | – |
| Q2 2016 | $100,000 | -9.9% | 18,424 | -22.6% | 0.00% | – |
| Q1 2016 | $111,000 | -6.7% | 23,803 | 0.0% | 0.00% | – |
| Q4 2015 | $119,000 | +2875.0% | 23,803 | +1689.7% | 0.00% | – |
| Q2 2014 | $4,000 | – | 1,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |